Sujets

Sur cette page, les lecteurs peuvent obtenir une liste de documents classifiés par thèmes. Cliquez sur le nom du thème pour voir affichées les sous-thèmes ou pour revenir aux thèmes principaux. Cliquez sur l'icône d'un sous-thème pour obtenir la liste des documents qui s'y rapportent. Les publications sont disponibles en HTML, PDF

, DOC

ou XLS

format. Veuillez cliquer sur l'icône correspondante pour accéder à la publication. La publication est disponible uniquement en format PDF lorsque l'icône PDF est située sur la page de couverture de la publication. Si l'icône PDF est située près du titre de la publication, les formats HTML et PDF sont disponibles.


		Page d'accueil de l'OMS

		OMS - Systèmes et services de santé

		OMS - Médicaments

		Sites OMS

		Page d'accueil - Publications et documents sur les médicaments

		Rechercher

		Titres A-Z

		Sujets

		Mots-clés

		Séries et Périodiques

		Éditeurs

		Auteurs A-Z

		Régions

		Pays

		Index

		Sous-collections

		Public sub-collections

Publications de l'OMS - Publications non-OMS - Tous

Anglais - Français - Espagnol - Russe

Étendre le menu Sous-collections.

248 documents en 8 pages

« Précédent | Suivant » | Tous | Détails

Afficher Tous | Cacher Tous

Medicine Information and Evidence for Policy

Medicines Policy

Ouvrir ce document et afficher son contenu

Titre:	An Audit of HIV/AIDS Policies in Botswana, Lesotho, Mozambique, South Africa, Swaziland and Zimbabwe
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Programme Coordination > Programme Coordination
Auteur:	Mosala, Thabang; Seager, John; Shisana, Olive; Udjo, Eric; Zungu-Dirwayi, Nompumelelo
An:	2004 Pages: 99
Éditeurs:	HSCR - Human Sciences Research Council
Régions:	Afrique (AFRO); SADC Southern African Development Community
Pays:	Botswana; Lesotho; Mozambique; Afrique du Sud; Swaziland; Zimbabwe

Titre:	Australian Guidelines for Drug Donations to Developing Countries. Endorsed by the Australian Pharmaceutical Advisory Council (APAC), November 1996 - Amendments Endorsed November 2000)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Supply Management
An:	2000 Pages: 11
Éditeurs:	Australian Government - Department of Health and Ageing
Liens associés:	http://www.health.gov.au/internet/main/publishing.nsf/Content/nmp-pdf-augudddc-cnt.htm
Pays:	Australie

Titre:	Australian National Drug Policies: Facilitating or Fragmenting Health?
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
Auteur:	Murray, Mary
An:	1995 Pages: 47
Documents similaires:	Making National Drug Policies a Development Priority. A Strategy Paper and Six Country Stories
Pays:	Australie

Titre:	Bangladesh: A Tough Battle for a National Drug Policy
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
Auteur:	Chowdhury, Zafrullah
An:	1995 Pages: 54
Documents similaires:	Making National Drug Policies a Development Priority. A Strategy Paper and Six Country Stories
Pays:	Bangladesh

Titre:	The Benefits of Responsible Use of Medicines. Setting Policies for Better and Cost-effective Healthcare. Ministers Summit, 3 October 2012, Amsterdam, the Netherlands. Report
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Rational Use
An:	2012 Pages: 15
Éditeurs:	Netherlands, Ministry of Health, Welfare and Sports
Liens associés:	http://www.government.nl/documents-and-publications/reports/2012/11/16/the-benefits-of-responsible-use-of-medicines.html
Régions:	Global

Titre:	Bhutan National Drug Policy 2007
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	2007 Pages: 18
Éditeurs:	Bhutan Ministry of Health
Pays:	Bhoutan

Titre:	BigPharma and Unethical Marketing of Medicinal Products - Southern Med Review Vol 4 Issue 2 Dec 2011
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Good Governance for Medicines
Auteur:	Myhr, Kirsten
An:	2011 Pages: 1
Régions:	Global

Titre:	Biosimilars. A Unique Opportunity for Iran National Health Sector and National Pharmaceutical Industry
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Quality and Safety: Medicines > Quality Assurance Quality and Safety: Medicines > Regulatory Support
Auteur:	Cheraghali, Abdol Majid
An:	2012 Pages: 4
Documents similaires:	Guidelines on Evaluation of Similar Biotherapeutic Products (SBPs). WHO Expert Committee on Biological Standardization, 19-23 October 2009
Liens associés:	http://www.darujps.com/content/20/1/35
Pays:	Iran (République islamique d')

Titre:	BMJ Research: New Evidence on the Impact of China’s New Rural Cooperative Medical Scheme and Its Implications for Rural Primary Healthcare: Multivariate Difference-In-Difference Analysis
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Financing
Auteur:	Miller, Grant; Rozelle, Scott; Singer, Kimberly Babiarz; Yi, Hongmei; Zhang, Linxiu
An:	2010 Pages: 9
Pays:	Chine

Titre:	A Call to Make Valuable Innovative Medicines Accessible in the European Union. Recommendations for a Coordinated Action to Stimulate, Measure and Valorise Pharmaceutical Innovation. Background Report for the Ministerial Conference, 23-24 September 2010 [French]
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Pricing
An:	2010 Pages: 55
Éditeurs:	European Union - Belgian Presidency of the Council of the European Union
Régions:	Europe (EURO)

Titre:	Code of Conduct for Pharmacists and Bodies Corporate, 2009 - Pharmacy Board Malaysia
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Rational Use
An:	2009 Pages: 39
Éditeurs:	Malaysia Ministry of Health
Pays:	Malaisie

Titre:	Code of Conduct for Registered Health Practitioners - Pharmacy Board of Australia
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	2010 Pages: 17
Éditeurs:	Australia - Pharmacy Board of Australia
Pays:	Australie

Titre:	Community-Based Participation and Initiatives. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 31)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Rational Use
Auteur:	Briggs, Jane
An:	2012 Pages: 17
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Computers in Pharmaceutical Management. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 50)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Supply Management
Auteur:	Frye, Julie
An:	2012 Pages: 24
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	The Concept of Essential Medicines: Lessons for Rich Countries
Sujets:	Medicine Information and Evidence for Policy > Information and Publications Medicine Information and Evidence for Policy > Medicines Policy
Auteur:	Hogerzeil, Hans V
An:	2004 Pages: 5
Régions:	Global

Titre:	Contracting for Pharmaceuticals and Services. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 39)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Supply Management
Auteur:	Gonsalkorale, Raj
An:	2012 Pages: 20
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Corporate Responsibilities for Access to Medicines
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Pricing
Auteur:	Leisinger, Klaus M.
An:	2009 Pages: 21
Éditeurs:	Novartis Foundation for Sustainable Development
Documents similaires:	Poverty, Disease and Medicines in Low- and Middle-income Countries: The Roles and Responsibilities of Pharmaceutical Corporations
Régions:	Global

Titre:	Delivering Universal Primary Care Services for Non-communicable Diseases: The Need for Stronger Country Health Systems (Commonwealth Health Ministers’ Update 2011, Chapter 4: Improving Disease Management, Access)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
Auteur:	Alwan, Ala; Etienne, Carissa; Samb, Badara; Van Bolhuis, Annemiek
An:	2011 Pages: 4
Éditeurs:	Commonwealth Secretariat Published by Pro-Brook Publishing Ltd
Régions:	Global

Titre:	Designing and Implementing Training Programs. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 52)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Programme Coordination > Human Resources for Pharmaceutical Sector
Auteur:	Holland, Ross
An:	2012 Pages: 20
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Developing Pharmacy Practice: A Focus on Patient Care. Handbook - 2006 Edition [French] [Spanish]
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Rational Use
Auteur:	Everard, Marthe; Gous, Andries G. S; Mackie, Clare A; Summers, Rob S; Tromp, Dick; Wiedenmayer, Karin
An:	2006 Pages: 97
Éditeurs:	WHO Headquarters in Geneva International Pharmaceutical Federation (FIP)
Régions:	Global


	« Précédent 1 2 3 4 5 6 7 8 Suivant »

Dernière mise à jour: le 3 mai 2013